Who Owns NRSN?

NeuroSense Therapeutics Ltd. — Institutional Ownership & 13F Holdings

$0.82

+0.02 (+2.11%)

Market Cap

$20.7M

Shares Outstanding

24,666,666

Institutional Holders

12

Total Inst. Value

$13.5B

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

1

Closed Positions

5

Increased

3

Decreased

4

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CLEAR STREET LLC$13.5B65,759
2MORGAN STANLEY$46K50,501
3MEITAV INVESTMENT HOUSE LTD$37K40,000
4XTX Topco Ltd$31K33,706
5COMMONWEALTH EQUITY SERVICES, LLC$16K17,250
6GEODE CAPITAL MANAGEMENT, LLC$14K15,870
7TWO SIGMA SECURITIES, LLC$14K14,705
8Warberg Asset Management LLC$12K20,700
9Hurley Capital, LLCNew$8K8,710
10UBS Group AG$3K5,116

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold NRSN?

As of Q1 2025, 12 institutional investors report holding NRSN (NeuroSense Therapeutics Ltd.) in their 13F filings.

Which hedge fund owns the most NRSN?

The largest institutional holder of NRSN is CLEAR STREET LLC with $13.5B in shares.

Are institutions buying or selling NRSN?

This quarter, 1 institutions opened new positions in NRSN and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.